Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jan 25, 2023 $5.34 $5.45 $5.17 $5.40 2 599 180
Jan 24, 2023 $5.42 $5.60 $5.35 $5.43 2 643 405
Jan 23, 2023 $5.59 $5.68 $5.33 $5.55 3 929 416
Jan 20, 2023 $5.78 $5.80 $5.45 $5.47 3 041 388
Jan 19, 2023 $5.77 $5.88 $5.59 $5.65 2 785 538
Jan 18, 2023 $5.78 $5.91 $5.60 $5.81 3 120 214
Jan 17, 2023 $5.73 $5.86 $5.57 $5.72 4 293 339
Jan 13, 2023 $5.83 $5.90 $5.38 $5.40 3 002 631
Jan 12, 2023 $5.73 $5.87 $5.35 $5.86 2 612 842
Jan 11, 2023 $5.49 $5.78 $5.32 $5.72 3 940 100
Jan 10, 2023 $5.15 $5.49 $5.07 $5.49 5 737 300
Jan 09, 2023 $4.32 $5.57 $4.30 $5.27 14 466 800
Jan 06, 2023 $4.38 $4.55 $4.02 $4.24 33 525 200
Jan 05, 2023 $11.24 $11.44 $10.54 $11.00 3 850 967
Jan 04, 2023 $10.42 $11.40 $10.38 $11.12 7 446 980
Jan 03, 2023 $9.94 $10.75 $9.92 $10.17 10 036 766
Dec 30, 2022 $9.85 $10.20 $9.56 $10.09 6 496 750
Dec 29, 2022 $10.01 $10.16 $9.79 $10.00 9 019 407
Dec 28, 2022 $10.14 $10.44 $9.79 $9.86 3 383 656
Dec 27, 2022 $10.90 $11.07 $9.88 $10.20 3 754 089
Dec 23, 2022 $11.66 $11.67 $10.89 $11.01 2 501 052
Dec 22, 2022 $11.55 $11.75 $10.95 $11.66 3 330 524
Dec 21, 2022 $12.75 $13.00 $12.15 $12.25 1 984 568
Dec 20, 2022 $12.64 $12.88 $12.41 $12.63 1 753 253
Dec 19, 2022 $13.08 $13.15 $12.43 $12.75 2 164 668
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT